The global Bovine Genetics Market was valued at USD 3.9 billion in 2025 and is projected to reach USD 6.7 billion by 2033, expanding at a CAGR of 7.1% from 2026 to 2033. The market is experiencing substantial growth due to increasing demand for high-yield livestock, advancements in reproductive and genomic technologies, and growing government support for livestock improvement programs...

The global Personalized Testing & Supplements Market was valued at USD 13.6 billion in 2025 and is projected to grow from USD 15.7 billion in 2026 to USD 46.3 billion by 2033, registering a remarkable CAGR of 16.7% from 2026 to 2033. The market is experiencing rapid expansion as consumers increasingly seek personalized health solutions tailored to their unique genetics,...

North America holds a substantial share of the Cancer Tissue Diagnostics Market, driven by its robust healthcare infrastructure, extensive cancer research activities, and growing emphasis on precision oncology. The region benefits from widespread adoption of advanced diagnostic technologies, including molecular pathology, immunohistochemistry, digital pathology, and genomic testing solutions....

The endonucleases market is experiencing robust growth as advancements in molecular biology, genetic engineering, and biotechnology continue to transform healthcare and life sciences research. Endonucleases are enzymes that cleave nucleic acid strands at specific internal sites, making them essential tools for DNA manipulation, gene editing, cloning, sequencing, and genome analysis. Their...

North America holds a dominant position in the Genomics Market due to its advanced healthcare infrastructure, strong research ecosystem, and early adoption of next-generation sequencing (NGS) technologies. The region is home to leading biotechnology and pharmaceutical companies, world-class academic institutions, and large-scale genomic research initiatives. The increasing focus on precision...

According to a newly published market research report by 24LifeSciences, global postoperative nausea and vomiting (PONV) market was valued at USD 1,958 million in 2024 and is projected to reach USD 3,117 million by 2031, growing at a compound annual growth rate (CAGR) of 7.0% during the forecast period 2025-2031. Postoperative nausea and vomiting (PONV), a common complication affecting...

According to a newly published market research report by 24LifeSciences, the global predictive and presymptomatic testing market was valued at USD 5.8 billion in 2024 and is projected to reach USD 16.3 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.9% during the forecast period 20252032. Predictive and presymptomatic testing involves the analysis of genetic,...

According to a newly published market research report by 24LifeSciences, the global prostate cancer diagnosis and therapy market was valued at USD 17.2 billion in 2024 and is projected to reach USD 23.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.8% during the forecast period 20252032. Prostate cancer, the second most common cancer in men globally, requires a...

Healthcare is no longer limited to treating diseases after symptoms appear. Modern medicine is increasingly focused on predicting health risks, preventing illness, and delivering treatments tailored to individual patients. At the center of this transformation is genetic testing, a technology that allows healthcare professionals to analyze genetic information and gain insights that were once...

Healthcare is rapidly evolving from generalized treatment approaches toward highly individualized medical care. At the center of this transformation lies laboratory testing, which provides precise biological data that helps doctors understand each patient’s unique health profile. Instead of relying solely on symptoms or standard treatment protocols, modern medicine increasingly depends on...